Literature DB >> 22394120

The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.

Adriano Mollica1, Francesco Pinnen, Azzurra Stefanucci, Federica Feliciani, Cristina Campestre, Luisa Mannina, Anatoly P Sobolev, Gino Lucente, Peg Davis, Josephine Lai, Shou-Wu Ma, Frank Porreca, Victor J Hruby.   

Abstract

Endomorphin-2 (EM-2: Tyr-Pro-Phe-Phe-NH(2)) is an endogenous tetrapeptide that combines potency and efficacy with high affinity and selectivity toward the μ opioid receptor, the most responsible for analgesic effects in the central nervous system. The presence of the Pro(2) represents a crucial factor for the ligand structural and conformational properties. Proline is in fact an efficient stereochemical spacer, capable of inducing favorable spatial orientation of aromatic rings, a key factor for ligand recognition and interaction with receptors. Here the Pro(2) has been replaced by 4(S)-NH(2)-2(S)-proline (cAmp), a proline/GABA cis-chimera residue. This bivalent amino acid maintains the capacity to influenc the tetrapeptide conformation and offers the opportunity to generate new linear models and unusually constrained cyclic analogues characterized by an N-terminal Tyr bearing a free α-amino group. The results indicate that the new analogues do not show affinity for both δ and κ opioid receptors and bind only poorly to the μ receptors (for cyclopeptide 9: K(i)(μ) = 660 nM; GPI (IC(50)) = 1.4% at 1 μM; for linear tetrapeptide acid 13: K(i)(μ) = 2000 nM; GPI (IC(50)) = 0% at 1 μM; for linear tetrapeptide amide 15: K(i)(μ) = 310 nM; GPI (IC(50)) = 894 nM).
© 2012 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22394120      PMCID: PMC5695669          DOI: 10.1021/jm201402v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  34 in total

Review 1.  The cyclization of peptides and depsipeptides.

Authors:  John S Davies
Journal:  J Pept Sci       Date:  2003-08       Impact factor: 1.905

2.  Structure-activity relationship of the novel bivalent and C-terminal modified analogues of endomorphin-2.

Authors:  Yanfeng Gao; Xin Liu; Jie Wei; Beibei Zhu; Qiang Chen; Rui Wang
Journal:  Bioorg Med Chem Lett       Date:  2005-04-01       Impact factor: 2.823

3.  Conformation of [Leu5]enkephalin from X-ray diffraction: features important for recognition at opiate receptor.

Authors:  D Smith; J F Griffin
Journal:  Science       Date:  1978-03-17       Impact factor: 47.728

Review 4.  Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.

Authors:  R Mentlein
Journal:  Regul Pept       Date:  1999-11-30

5.  Conformational preferences of [Leu5]enkephalin in biomimetic media. Investigation by 1H NMR.

Authors:  D Picone; A D'Ursi; A Motta; T Tancredi; P A Temussi
Journal:  Eur J Biochem       Date:  1990-09-11

6.  Peptides containing 4-amino-1,2-dithiolane-4-carboxylic acid (Adt): conformation of Boc-Adt-Adt-NHMe and NH...S interactions.

Authors:  Enrico Morera; Marianna Nalli; Adriano Mollica; Mario Paglialunga Paradisi; Massimiliano Aschi; Enrico Gavuzzo; Fernando Mazza; Gino Lucente
Journal:  J Pept Sci       Date:  2005-02       Impact factor: 1.905

7.  Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.

Authors:  G Pagani Zecchini; M Nalli; A Mollica; G Lucente; M Paglialunga Paradisi; S Spisani
Journal:  J Pept Res       Date:  2002-06

8.  Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2.

Authors:  Cesare Giordano; Anna Sansone; Annalisa Masi; Gino Lucente; Pasqualina Punzi; Adriano Mollica; Francesco Pinnen; Federica Feliciani; Ivana Cacciatore; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor Hruby
Journal:  Eur J Med Chem       Date:  2010-07-21       Impact factor: 6.514

9.  Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.

Authors:  Domenica Torino; Adriano Mollica; Francesco Pinnen; Federica Feliciani; Susanna Spisani; Gino Lucente
Journal:  Bioorg Med Chem       Date:  2008-11-12       Impact factor: 3.641

10.  Hybrid alpha/beta-peptides: for-Met-Leu-Phe-OMe analogues containing geminally disubstituted beta2,2- and beta 3,3-amino acids at the central position.

Authors:  A Mollica; M Paglialunga Paradisi; D Torino; S Spisani; G Lucente
Journal:  Amino Acids       Date:  2006-03-20       Impact factor: 3.520

View more
  5 in total

1.  Synthesis of mixed opioid affinity cyclic endomorphin-2 analogues with fluorinated phenylalanines.

Authors:  Justyna Piekielna; Renata Perlikowska; Jean Claude do-Rego; Jean-Luc do-Rego; Maria Camilla Cerlesi; Girolamo Calo; Alicja Kluczyk; Krzysztof Łapiński; Csaba Tömböly; Anna Janecka
Journal:  ACS Med Chem Lett       Date:  2015-04-03       Impact factor: 4.345

2.  Novel cyclic biphalin analogue with improved antinociceptive properties.

Authors:  Adriano Mollica; Alfonso Carotenuto; Ettore Novellino; Antonio Limatola; Roberto Costante; Francesco Pinnen; Azzurra Stefanucci; Stefano Pieretti; Anna Borsodi; Reza Samavati; Ferenc Zador; Sándor Benyhe; Peg Davis; Frank Porreca; Victor J Hruby
Journal:  ACS Med Chem Lett       Date:  2014-07-14       Impact factor: 4.345

3.  Structural and biological exploration of phe(3)-phe(4)-modified endomorphin-2 peptidomimetics.

Authors:  Giordano Lesma; Severo Salvadori; Francesco Airaghi; Thomas F Murray; Teresa Recca; Alessandro Sacchetti; Gianfranco Balboni; Alessandra Silvani
Journal:  ACS Med Chem Lett       Date:  2013-07-11       Impact factor: 4.345

Review 4.  Cyclic Opioid Peptides.

Authors:  Michael Remesic; Yeon Sun Lee; Victor J Hruby
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

5.  An Effective and Safe Enkephalin Analog for Antinociception.

Authors:  K K DurgaRao Viswanadham; Roland Böttger; Lukas Hohenwarter; Anne Nguyen; Elham Rouhollahi; Alexander Smith; Yi-Hsuan Tsai; Yuan-Yu Chang; Christopher Llynard Ortiz; Lee-Wei Yang; Liliana Jimenez; Siyuan Li; Chan Hur; Shyh-Dar Li
Journal:  Pharmaceutics       Date:  2021-06-22       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.